55 research outputs found

    RANTES/CCL5 and risk for coronary events: Results from the MONICA/KORA Augsburg case-cohort, Athero-express and CARDIoGRAM studies

    Get PDF
    Background: The chemokine RANTES (regulated on activation, normal T-cell expressed and secreted)/CCL5 is involved in the pathogenesis of cardiovascular disease in mice, whereas less is known in humans. We hypothesised that its relevance for atherosclerosis should be reflected by associations between CCL5 gene variants, RANTES serum concentrations and protein levels in atherosclerotic plaques and risk for coronary events. Methods and Findings: We conducted a case-cohort study within the population-based MONICA/KORA Augsburg studies. Baseline RANTES serum levels were measured in 363 individuals with incident coronary events and 1,908 non-cases (mean follow-up: 10.2±

    Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

    Get PDF
    BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

    Terahertz time domain spectroscopy and imaging: Emerging techniques for food process monitoring and quality control

    Get PDF
    The Terahertz (THz) region of the electromagnetic spectrum, spanning the range between 100 GHz and 30 THz, has recently enjoyed a renaissance due to technological developments in source and detector components. With the development of THz instrumentation, applications of THz spectroscopy and imaging for quality control of food products have expanded in scope and improved in performance. This article gives an overview of the fundamentals of THz technology and a comprehensive review of applications of THz time domain spectroscopy and imaging for food quality and control. Technical challenges and future outlook for these emerging techniques are also discussed

    Use of spectral pre-processing methods to compensate for the presence of packaging film in visible–near infrared hyperspectral images of food products

    No full text
    The presence of polymeric packaging film in images of food products may modify spectra obtained in hyperspectral imaging (HSI) experiments, leading to undesirable image artefacts which may impede image classification. Some pre-processing of the image is typically required to reduce the presence of such artefacts. The objective of this research was to investigate the use of spectral pre-processing techniques to compensate for the presence of packaging film in hyperspectral images obtained in the visible–near infrared wavelength range (445–945 nm), with application in food quality assessment. A selection of commonly used pre-processing methods, used individually and in combination, were applied to hyperspectral images of flat homogeneous samples, imaged in the presence and absence of different packaging films (polyvinyl chloride and polyethylene terephthalate). Effects of the selected pre-treatments on variation due to the film’s presence were examined in principal components score space. The results show that the combination of first derivative Savitzky–Golay followed by standard normal variate transformation was useful in reducing variations in spectral response caused by the presence of packaging film. Compared to other methods examined, this combination has the benefits of being computationally fast and not requiring a priori knowledge about the sample or film used
    • 

    corecore